Seventy-five patients were randomized to receive supraclavicular block using 30-mL bupivacaine 0.5 % alone ( Control ) , with concomitant intravenous dexamethasone 8 mg ( DexIV ) , or with perineural dexamethasone 8 mg ( DexP ) .